IWTI 2016

JONS talks to navigators Trish Leighton, Stephanie Hoopes, and Jo Weathers about their team-driven approach to patient care.

The publishers of JONS had the pleasure of speaking with Drs Dempsey and Song about their multiple-template strategy that analyzes ctcDNA and ccfDNA in blood as well as the initiation of their clinical trial in triple-negative breast cancer.

In recent years, we have heard that cancer is becoming a chronic condition with patients benefiting from personalized treatment strategies, including biomarker identification and related targeted therapies and immunotherapies.

In an effort to learn more about NCI-MATCH, we asked the Acting Director, Douglas R. Lowy, MD, to speak with us. What follows is our exchange.

JONS speaks with Lillie D. Shockney, RN, BS, MAS, about the role of the navigator in personalizing care for oncology patients and the future for the profession.